About Leo Linbeck III
Leo Linbeck III is an executive officer at Goldenrod Therapeutics.
Form D filings also name Leo Linbeck III as a director at Pulmotect.
Leo Linbeck III first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Leo Linbeck III in the role, so the role may have started earlier or lasted longer.
Goldenrod Therapeutics, Inc.
Executive officer
2026 · Houston, TX
Develops medicines for people with neurological diseases, initially targeting Friedreich’s ataxia.
Key Colleagues at Startups
The people Leo Linbeck III works with at each company, as listed on that company's latest Form D.
Goldenrod Therapeutics, Inc. · Form D, Jun 3, 2026
Dev Chatterjee
Chief Executive Officer
Mark Worscheh
Chief Financial Officer and director
Atul Varadhachary
President and director
TB
Thomas Brenninkmeijer
Director
Pulmotect, Inc. · Form D, Sep 9, 2024
Kumar Srinivasan
Director
MH
Magnus Hook
Director
Atul Varadhachary
Director
CB
Colin Broom
Executive officer and director
BG
Bruce Given
Director
BS
Brenton Scott
Director